BAM
IDXX icon

Bellevue Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bellevue Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3
Closed -$2.03K – 432
2025
Q4 		$2.03K Sell
3
-1
-25% -$681 ﹤0.01% 436
2025
Q3 		$2.56K Buy
4
+1
+33% +$607 ﹤0.01% 414
2025
Q2 		$1.61K Hold
3
– – ﹤0.01% 450
2025
Q1 		$1.26K Buy
+3
New +$1.3K ﹤0.01% 457
2024
Q4 		– Sell
-2
Closed -$1.01K – 502
2024
Q3 		$1.01K Buy
+2
New +$972 ﹤0.01% 458
2024
Q2 		– Sell
-2
Closed -$1.08K – 469
2024
Q1 		$1.08K Buy
+2
New +$1.09K ﹤0.01% 455
2023
Q3 		– Sell
-2
Closed -$1K – 467
2023
Q2 		$1K Hold
2
– – ﹤0.01% 478
2023
Q1 		$1K Sell
2
-1
-33% -$479 ﹤0.01% 484
2022
Q4 		$1.21K Buy
+3
New +$1.17K ﹤0.01% 466

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bellevue Asset Management's IDXX Position: Q1 2026 in Review

Bellevue Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 3 shares — an estimated $2.03K sold.

Bellevue Asset Management first reported a position in IDXX in Q4 2022 and held it in 9 quarters. The position peaked at $2.56K in Q3 2025. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Bellevue Asset Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Bellevue Asset Management sold 3 Idexx Laboratories shares in Q1 2026, an estimated $2.03K.
  • Bellevue Asset Management first reported a position in Idexx Laboratories in Q4 2022 and held it in 9 quarters.
  • Bellevue Asset Management's Idexx Laboratories position peaked at $2.56K in Q3 2025.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Bellevue Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.